Klaus Kuhlcke

Idar, RP, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Stable and Predictable Lentiviral Vector Production at Clinical Scale.

Stable and Predictable Lentiviral Vector Production at Clinical Scale.

Journal: Human gene therapy
Published: November 21, 2025

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.

Journal: Nature medicine
Published: August 04, 2023

An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors.

An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors.

Journal: Science (New York, N.Y.)
Published: July 02, 2019

Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation.

Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation.

Journal: Journal of translational medicine
Published: March 23, 2015

Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma.

Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma.

Journal: Gene therapy
Published: February 13, 2015

HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNA.

HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNA.

Journal: Human gene therapy. Clinical development
Published: November 11, 2014

Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing.

Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing.

Journal: Current gene therapy
Published: October 15, 2014

Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor.

Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 11, 2014

Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.

Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.

Journal: Science translational medicine
Published: March 14, 2014

From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease.

From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease.

Journal: Human gene therapy. Clinical development
Published: July 13, 2013
Showing 1-10 of 10

Last Updated: 09/26/2026